New Genetic Sensor Enables MRI to Image Molecular-Level Changes

Researchers develop a system that allows MRI to visualize cellular activity in real-time, transforming the study of cancer and neurodegeneration.

Apr. 4, 2026 at 7:48pm

Got story updates? Submit your updates here. ›

Researchers at the University of California, Santa Barbara have developed a genetically encoded protein-based sensor called MAPPER that enables MRI to visualize molecular-level cellular activity in real-time. The system utilizes aquaporin proteins to manipulate water molecule movement, creating a magnetic signal that reveals chemical processes before structural damage occurs. This modular 'LEGO-like' architecture can be tailored to detect multiple different analytes, potentially transforming the study of cancer metastasis and neurodegeneration.

Why it matters

The fundamental limitation of traditional MRI has been its reliance on anatomical changes, creating a diagnostic gap where pathogenesis is often well underway at the molecular level before it manifests as visible tissue damage. The MAPPER system shifts the focus from macro-structures to the behavior of water molecules within the cell, allowing MRI to 'observe' molecular activity as it happens and potentially enabling earlier detection and intervention for diseases like cancer and neurodegeneration.

The details

The MAPPER system leverages aquaporin—a protein that forms hourglass-shaped channels in the cell membrane to regulate water flow. By genetically engineering these sensors into cells, the MRI can pick up a specific magnetic signal based on the rate of water molecule movement across the cell membrane, rather than the presence of a mass. This modular 'LEGO-like' architecture can be tailored to detect multiple different analytes, providing flexibility to target various cellular processes.

  • The MAPPER system was developed by researchers at the University of California, Santa Barbara and detailed in the peer-reviewed journal Science Advances.
  • The MAPPER system is currently in the research and development phase, with the goal of transitioning the technology from the benchtop to clinical application.

The players

Arnab Mukherjee

Associate Professor of Chemical Engineering at the University of California, Santa Barbara and a key researcher behind the development of the MAPPER system.

Asish Ninan Chacko

PhD researcher involved in the development of the MAPPER system, which allows for continuous imaging of the same animal over the course of a study, reducing the number of animals required and increasing the reliability of the data.

University of California, Santa Barbara

The institution where the MAPPER system was developed by a team of researchers.

Science Advances

The peer-reviewed journal that published the research detailing the MAPPER system.

MRI Research Institute (MRIRI) at Weill Cornell Medicine

A research institute focused on developing quantitative methods and data science techniques to improve disease detection and precision medicine, which could potentially integrate the MAPPER system into its existing research frameworks.

Got photos? Submit your photos here. ›

What they’re saying

“If we can see these molecular-level changes happening in real time, then we can ask questions like, 'How do tumor cells metastasize?' or 'How does neurodegeneration progress at the molecular level as an animal ages?'”

— Arnab Mukherjee, Associate Professor of Chemical Engineering, UCSB

“Our approach allows continuous imaging of the same animal over the course of a study, giving a far more accurate picture of disease and of biology.”

— Asish Ninan Chacko, PhD researcher

What’s next

The MAPPER system represents a leap forward in molecular diagnostics, but the path to widespread clinical adoption involves significant regulatory and technical hurdles. Integrating genetically encoded sensors into human medicine requires rigorous safety profiles and FDA oversight. In the interim, the focus remains on refining these tools in laboratory settings and animal models to ensure absolute specificity and sensitivity.

The takeaway

The MAPPER system's ability to track molecular changes in real-time has profound implications for the standard of care in oncology and neurology, potentially enabling earlier detection and intervention for diseases like cancer and neurodegeneration. This transition from anatomy to activity-based imaging represents a broader trend in radiology, as the integration of molecular sensors like MAPPER into existing research frameworks could accelerate the translation of this technology from the benchtop to the bedside.